These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18329534)

  • 1. Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenon.
    Flavahan NA
    Rheum Dis Clin North Am; 2008 Feb; 34(1):81-7; vii. PubMed ID: 18329534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cold and emotional stress in Raynaud's disease and scleroderma.
    Freedman RR; Ianni P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal regulators and vascular dysfunction in Raynaud's phenomenon and systemic sclerosis.
    Fonseca C; Abraham D; Ponticos M
    Curr Vasc Pharmacol; 2009 Jan; 7(1):34-9. PubMed ID: 19149638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis of Raynaud's phenomenon, disease and syndrome].
    Bartolo M; Antignami PL; Cestari M; Rufini E
    Angiologia; 1985; 37(4):161-70. PubMed ID: 4025912
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenon.
    Fava A; Wung PK; Wigley FM; Hummers LK; Daya NR; Ghazarian SR; Boin F
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):925-9. PubMed ID: 22275160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrared functional imaging applied to Raynaud's phenomenon.
    Merla A; Di Donato L; Di Luzio S; Farina G; Pisarri S; Proietti M; Salsano F; Romani GL
    IEEE Eng Med Biol Mag; 2002; 21(6):73-9. PubMed ID: 12613214
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiological classification of Raynaud's phenomenon.
    Nilsen KH
    Br J Dermatol; 1980 Jan; 102(1):1-5. PubMed ID: 7378276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's phenomenon.
    Wigley FM; Flavahan NA
    Rheum Dis Clin North Am; 1996 Nov; 22(4):765-81. PubMed ID: 8923595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon.
    Furspan PB; Chatterjee S; Mayes MD; Freedman RR
    Rheumatology (Oxford); 2005 Apr; 44(4):488-94. PubMed ID: 15695304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis.
    Sunderkötter C; Riemekasten G
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii33-5. PubMed ID: 16987831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
    Wigley FM
    Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an abnormal peripherally mediated vascular response to temperature in Raynaud's phenomenon.
    Walmsley D; Goodfield MJ
    Br J Rheumatol; 1990 Jun; 29(3):181-4. PubMed ID: 2357499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of a selective alpha(2C)-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study.
    Wise RA; Wigley FM; White B; Leatherman G; Zhong J; Krasa H; Kambayashi J; Orlandi C; Czerwiec FS
    Arthritis Rheum; 2004 Dec; 50(12):3994-4001. PubMed ID: 15593189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cold hypersenstivity in Raynaud's phenomenon.
    Jamieson GG; Ludbrook J; Wilson A
    Circulation; 1971 Aug; 44(2):254-64. PubMed ID: 4327362
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative assessment of the effects of vasodilators on peripheral vascular reactivity in patients with systemic scleroderma and Raynaud's phenomenon: color Doppler flow imaging study.
    Aikimbaev KS; Oğuz M; Ozbek S; Demirtaş M; Birand A; Batyraliev T
    Angiology; 1996 May; 47(5):475-80. PubMed ID: 8644944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Raynaud's syndrome: study of fingertip blood flow by plethysmography with venous occlusion (author's transl)].
    Cristol R; Graisely B; Cloarec M; Debray J
    Nouv Presse Med; 1979 Jan; 8(2):105-8. PubMed ID: 554069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential diagnosis of Raynaud's phenomenon.
    Wigley FM
    Hosp Pract (Off Ed); 1991 Jul; 26(7):63-70, 73-84. PubMed ID: 2071684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.